Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,139.04
-7.99
(-0.10%)
FTSE 250
19,988.34
-96.45
(-0.48%)
AIM
761.43
-1.90
(-0.25%)
GBP/EUR
1.1714
+0.0001
(+0.01%)
GBP/USD
1.2525
-0.0037
(-0.30%)
Bitcoin GBP
50,119.69
-539.11
(-1.06%)
Stocks
Trending tickers: Amazon, Tesla, Samsung, Mercedes-Benz, Whitbread
The latest investor updates on stocks that are trending on Tuesday
Citius Pharmaceuticals, Inc. (CTXR)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7296
+0.0376
(+5.43%)
As of 11:29AM EDT. Market open.
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
13,996
14,820
17,655
12,241
8,813
Selling general and administrative
24,827
21,912
15,661
11,291
8,898
Total operating expenses
38,823
36,732
33,316
23,532
17,711
Operating income or loss
-38,823
-36,732
-33,316
-23,532
-17,711
Interest expense
-
-
0
10.839
15.673
Total other income/expenses net
-
3,586
-
226.474
110.207
Income before tax
-37,604
-31,967
-33,065
-23,054
-17,548
Income tax expense
576
576
576
0
0
Income from continuing operations
-38,180
-32,543
-33,641
-23,054
-17,548
Net income
-38,180
-32,543
-33,641
-23,054
-17,548
Net income available to common shareholders
-39,332
-33,694
-33,641
-24,505
-17,548
Basic EPS
-0.22
-0.22
-0.23
-0.23
-0.45
Diluted EPS
-0.22
-0.22
-0.23
-0.23
-0.45
Basic average shares
151,295
151,295
146,082
108,599
39,165
Diluted average shares
151,295
151,295
146,082
108,599
39,165
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.